IL10 and COVID-19: IL-10 produced by Tregs plays an antifibrotic role and significantly contributes to the inhibition on fibroproliferation (98), suggesting that targeting Tregs could be a potential strategy to treat pulmonary fibrosis in severe COVID-19 patients.